Total Payments
$17,349
2024 Payments
$1,026
Companies
41
Transactions
327
Medicare Patients
2,714
Medicare Billing
$235,930
Payment Breakdown by Category
Research$7,490 (43.2%)
Food & Beverage$6,452 (37.2%)
Travel$3,401 (19.6%)
Education$5.90 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,490 | 22 | 43.2% |
| Food and Beverage | $6,452 | 293 | 37.2% |
| Travel and Lodging | $3,401 | 11 | 19.6% |
| Education | $5.90 | 1 | 0.0% |
Payments by Type
General
$9,859
305 transactions
Research
$7,490
22 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk AS | $4,665 | 13 | $0 (2022) |
| SANOFI US SERVICES INC. | $2,793 | 7 | $0 (2019) |
| GlaxoSmithKline, LLC. | $1,403 | 11 | $0 (2024) |
| AstraZeneca UK Limited | $1,338 | 7 | $0 (2020) |
| Radius Health, Inc. | $1,280 | 11 | $0 (2019) |
| Novo Nordisk Inc | $906.80 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $747.76 | 34 | $0 (2024) |
| Janssen Research & Development, LLC | $697.61 | 11 | $0 (2018) |
| Amgen Inc. | $337.31 | 22 | $0 (2024) |
| Eli Lilly and Company | $297.28 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,026 | 42 | AstraZeneca Pharmaceuticals LP ($176.18) |
| 2023 | $496.13 | 26 | Novo Nordisk Inc ($194.38) |
| 2022 | $3,966 | 36 | Novo Nordisk AS ($3,377) |
| 2021 | $473.06 | 25 | AstraZeneca Pharmaceuticals LP ($192.78) |
| 2020 | $2,006 | 47 | AstraZeneca UK Limited ($1,338) |
| 2019 | $4,713 | 57 | Novo Nordisk AS ($1,288) |
| 2018 | $2,867 | 54 | SANOFI US SERVICES INC. ($1,545) |
| 2017 | $1,800 | 40 | GlaxoSmithKline, LLC. ($1,319) |
All Payment Transactions
327 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Endocrinology | ||||||
| 10/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Obesity | ||||||
| 09/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Biological | ||||||
| 09/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Diabetes Care | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: Cardiovascular | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: Neuroscience | ||||||
| 07/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Oncology | ||||||
| 07/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Endocrinology | ||||||
| 07/17/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $143.98 | General |
| Category: WATCHMAN_IC | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Respiratory | ||||||
| 07/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Biological | ||||||
| 06/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Obesity | ||||||
| 06/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN9535-4321 & EX9924-4473 | Novo Nordisk AS | $1,811 | 6 |
| A Clinical Outcomes Study to compare the effect of Fluticasone Furoate Vilanterol Inhalation Powder 100 25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease COPD and a history of or at increased risk for cardiov | GlaxoSmithKline, LLC. | $1,319 | 6 |
| A 56-week, Multicenter, Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly Compared to Dulaglutide Once Weekly in Patients With Type 2 Dia | SANOFI US SERVICES INC. | $1,248 | 3 |
| A 56-week, Multicenter, Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly Compared to Dulaglutide Once Weekly in Patients with Type 2 Dia | SANOFI US SERVICES INC. | $1,248 | 3 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | Eli Lilly and Company | $297.28 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 691 | 1,263 | $151,978 | $66,399 |
| 2022 | 15 | 635 | 1,120 | $134,109 | $60,006 |
| 2021 | 13 | 693 | 1,307 | $137,133 | $61,703 |
| 2020 | 15 | 695 | 1,114 | $118,002 | $47,822 |
Total Patients
2,714
Total Services
4,804
Medicare Billing
$235,930
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 278 | $57,824 | $23,366 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 103 | 103 | $23,072 | $12,620 | 54.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 29 | 214 | $26,536 | $9,755 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 85 | $11,985 | $4,834 | 40.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 123 | $8,979 | $4,311 | 48.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 49 | 49 | $5,978 | $3,628 | 60.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 14 | 14 | $5,054 | $1,950 | 38.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $3,984 | $1,887 | 47.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 51 | $1,785 | $1,468 | 82.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 83 | $1,981 | $782.27 | 39.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 63 | 67 | $2,211 | $588.60 | 26.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 23 | 31 | $1,178 | $532.58 | 45.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $595.00 | $293.08 | 49.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 33 | 88 | $528.00 | $279.83 | 53.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 34 | 48 | $288.00 | $105.60 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 238 | $49,504 | $20,173 | 40.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 90 | 90 | $20,160 | $11,333 | 56.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 25 | 195 | $21,525 | $9,034 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 96 | $13,536 | $5,877 | 43.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 19 | 101 | $7,373 | $3,490 | 47.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 35 | 35 | $4,270 | $2,459 | 57.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 16 | 16 | $5,776 | $2,189 | 37.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $4,086 | $2,100 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 42 | $1,470 | $1,174 | 79.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 37 | 75 | $1,764 | $680.88 | 38.6% |
About Dr. Nidaa Khamousia, M.D
Dr. Nidaa Khamousia, M.D is a Internal Medicine healthcare provider based in Maumee, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184687014.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nidaa Khamousia, M.D has received a total of $17,349 in payments from pharmaceutical and medical device companies, with $1,026 received in 2024. These payments were reported across 327 transactions from 41 companies. The most common payment nature is "" ($7,490).
As a Medicare-enrolled provider, Khamousia has provided services to 2,714 Medicare beneficiaries, totaling 4,804 services with total Medicare billing of $235,930. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Maumee, OH
- Active Since 04/11/2006
- Last Updated 05/09/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1184687014
Products in Payments
- Ozempic (Drug) $2,139
- SAR439977 (Drug) $1,545
- EFPEGLENATIDE (Drug) $1,248
- FARXIGA (Drug) $650.48
- ENTRESTO (Drug) $203.67
- Vascepa (Drug) $193.56
- Tresiba (Drug) $173.88
- Cologuard Collection Kit (Device) $148.75
- EVENITY (Biological) $147.59
- Livalo (Drug) $146.36
- WATCHMAN Access System (Device) $143.98
- Kerendia (Drug) $140.45
- Korlym (Drug) $138.74
- JANUVIA (Drug) $122.90
- VRAYLAR (Drug) $112.85
- Prolia (Biological) $112.35
- SPRAVATO (Drug) $103.59
- Rybelsus (Drug) $97.27
- FREESTYLE LIBRE 3 (Device) $81.11
- UBRELVY (Drug) $79.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Maumee
Dr. Nizar Daboul, M.d, M.D
Internal Medicine — Payments: $88,959
Internal Medicine $88,959
Munir Shah, Md, MD
Internal Medicine — Payments: $24,465
Internal Medicine $24,465
Richard Paat, M.d, M.D
Internal Medicine — Payments: $1,143
Internal Medicine $1,143
Allen Schwisow, M.d, M.D
Internal Medicine — Payments: $888.56
Internal Medicine $888.56
Jamal Saleh, M.d, M.D
Internal Medicine — Payments: $244.81
Internal Medicine $244.81
Robert Stierwalt, Md, MD
Internal Medicine — Payments: $128.80
Internal Medicine $128.80